Does USTEKINUMAB Cause Multiple sclerosis? 108 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Multiple sclerosis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.1% of all adverse event reports for USTEKINUMAB.
108
Reports of Multiple sclerosis with USTEKINUMAB
0.1%
of all USTEKINUMAB reports
1
Deaths
16
Hospitalizations
How Dangerous Is Multiple sclerosis From USTEKINUMAB?
Of the 108 reports, 1 (0.9%) resulted in death, 16 (14.8%) required hospitalization.
Is Multiple sclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Multiple sclerosis?
DIMETHYL (5,074)
NATALIZUMAB (4,078)
INTERFERON BETA-1A (3,412)
OCRELIZUMAB (2,609)
GLATIRAMER (2,596)
DALFAMPRIDINE (2,224)
FINGOLIMOD (2,123)
TERIFLUNOMIDE (1,983)
OFATUMUMAB (1,267)
DIROXIMEL (978)
Which USTEKINUMAB Alternatives Have Lower Multiple sclerosis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE